Your session is about to expire
← Back to Search
Orthopedic Implant
Short-Stemmed with Augmented Fixation for Osteoarthritis
N/A
Waitlist Available
Led By Brent A Lanting, MD, FRCSC
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients undergoing a first total knee revision surgery
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-2 weeks (baseline exam) to 1 year
Awards & highlights
Study Summary
This trial is investigating whether long-stemmed or short-stemmed implants are better for revision total knee replacement, as well as comparing patient outcomes and costs.
Eligible Conditions
- Osteoarthritis
- Total Knee Arthroplasty
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0-2 weeks (baseline exam) to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-2 weeks (baseline exam) to 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Implant Migration Over Time
Secondary outcome measures
Euro-Quol Group EQ-5D
Inducible displacement of the tibial component
KOOS Knee Survey
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Short-Stemmed with Augmented FixationExperimental Treatment1 Intervention
Participants will receive the Short-Stemmed primary implant with Augmented Fixation during their surgery.
Group II: Long-Stemmed with Hybrid FixationActive Control1 Intervention
Participants will receive the Long-Stemmed revision implant with Hybrid Fixation during their surgery.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Short-Stemmed with Augmented Fixation
2018
N/A
~20
Find a Location
Who is running the clinical trial?
Lawson Health Research InstituteLead Sponsor
656 Previous Clinical Trials
413,416 Total Patients Enrolled
21 Trials studying Osteoarthritis
5,555 Patients Enrolled for Osteoarthritis
Brent A Lanting, MD, FRCSCPrincipal InvestigatorLondon Health Sciences Centre
1 Previous Clinical Trials
96 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger